4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-061294
Director bought 5,000 shares at an average $1.89 ($9,436)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quimi Daphne Director | 2024-05-14 | Purchase | +2,750 | $1.89 | $5,184 | 2,750 | D |
| Quimi Daphne Director | 2024-05-15 | Purchase | +2,250 | $1.89 | $4,252 | 5,000 | D |
| Open-market purchases · 5,000 sh · avg $1.89 · $9,436 | |||||||
Loading xslF345X05/ownership.xml…